New Weight-Loss drug candidate enters early human testing

This early-stage study is testing a new drug called IBI3032 in 79 adults who are overweight or have obesity. The main goal is to check if the drug is safe and how the body processes it over a 4-week treatment period. Participants receive either the drug or a placebo, and researchers monitor side effects and drug levels in the blood. This is a first step to see if IBI3032 might help control weight, but it is not yet proven as a treatment.